{"id":"vorinostat-vor","safety":{"commonSideEffects":[{"rate":"~40%","effect":"Nausea"},{"rate":"~30%","effect":"Diarrhea"},{"rate":"~25%","effect":"Fatigue"},{"rate":"~20%","effect":"Anorexia"},{"rate":"~15%","effect":"Thrombocytopenia"},{"rate":"~5%","effect":"QT prolongation"}]},"_chembl":null,"_dailymed":{"setId":"cd86ee78-2781-468b-930c-3c4677bcc092","title":"ZOLINZA (VORINOSTAT) CAPSULE [MERCK SHARP & DOHME LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By blocking HDAC enzymes, vorinostat increases histone acetylation, which opens chromatin structure and allows transcription of genes involved in cell cycle arrest and apoptosis. This epigenetic mechanism is particularly effective in certain hematologic malignancies where HDAC inhibition triggers differentiation and death of cancer cells. The drug also induces reactive oxygen species and disrupts protein chaperone function.","oneSentence":"Vorinostat inhibits histone deacetylases (HDACs), leading to accumulation of acetylated histones and altered gene expression that promotes cancer cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:27:44.862Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cutaneous T-cell lymphoma (mycosis fungoides)"},{"name":"Peripheral T-cell lymphoma"}]},"trialDetails":[{"nctId":"NCT07217379","phase":"PHASE1","title":"The DART DELIVER-02 Study","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-10-02","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":24},{"nctId":"NCT02316340","phase":"PHASE2","title":"Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2015-02-11","conditions":"Colorectal Cancer","enrollment":42},{"nctId":"NCT03212989","phase":"PHASE1","title":"Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-06-27","conditions":"HIV-1 Infection","enrollment":17},{"nctId":"NCT03803605","phase":"PHASE1","title":"Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-02-12","conditions":"HIV-1 Infection","enrollment":15},{"nctId":"NCT02707900","phase":"PHASE1","title":"Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-03","conditions":"HIV-1 Infection","enrollment":6},{"nctId":"NCT01319383","phase":"PHASE1, PHASE2","title":"The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-02","conditions":"HIV-1 Infection","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":50,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zolinza"],"phase":"marketed","status":"active","brandName":"Vorinostat (VOR)","genericName":"Vorinostat (VOR)","companyName":"University of North Carolina, Chapel Hill","companyId":"university-of-north-carolina-chapel-hill","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vorinostat is a small molecule histone deacetylase 1 inhibitor, classified as an INHIBITOR. It has been studied in clinical trials for conditions including HIV-1 Infection, HIV, and Colorectal Cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}